Global Continuous Renal Replacement Therapy Market is expected to foresee significant growth during the forecast period. North America to witness the highest growth
Global Continuous Renal Replacement Therapy Market is expected to reach the market valuation of US$ XX million by 2027 expanding at a reasonable CAGR of XX% during the forecast period (2021-2027F) from US$ XX million in 2020. Continuous Renal Replacement Therapy is a slower type of dialysis that puts less stress on the heart. Instead of doing it over four hours, CRRT is done 24 hours a day to slowly and continuously clean out waste products and fluid from the patient. It requires special anticoagulation to keep the dialysis circuit from clotting
The growing worldwide incidence of AKI/AKF is, therefore, expected to increase the demand for CRRT. According to the International Society of Nephrology (INR), an estimated 13.3 million cases of AKI are registered annually worldwide. This is anticipated to boost the adoption of continuous renal replacement therapy at a rapid rate. With the rapid growth in the geriatric population globally, the prevalence of kidney-related diseases is expected to increase significantly. This, in turn, is expected to propel the growth of the CRRT market at a significant rate during the forecast period.
For a detailed analysis of the Continuous Renal Replacement Therapy browse through – https://univdatos.com/report/continuous-renal-replacement-therapy-market/
In continual and slow extracorporeal blood purification therapy for kidney failure patients, Continuous Renal Replacement Therapy (CRRT) is used. For the constant, slow elimination of fluid and solutes, CRRT mimics the kidneys’ methods in controlling water, electrolytes, and toxic compounds. Continuous renal replacement treatment (CRRT) is reserved for patients who are suitable for hemodialysis but unable to tolerate traditional intermittent hemodialysis (IHD) due to hemodynamic instability. The demand for CRRT has risen since the device helps surgeons in removing solutes from blood and tissue. In addition, the growing elderly population and the rise in acute renal disease instances are expected to boost the market. Furthermore, the rising number of coronavirus positive cases, primarily among the elderly, and the rising prevalence of kidney cases among critically sick patients are projected to increase demand for continuous renal replacement treatment. For instance, In 2019, Baxter International Inc. introduced the PrisMax CRRT system in the US.
The COVID-19 pandemic has significantly affected the CRRT market. The surge in the number of COVID cases, along with the rise in its severity rate, is likely to create a potential increase in the incidence of kidney damage. This makes AKI the next emerging healthcare concern after respiratory tract infections among patients with COVID-19. Due to the pandemic, the demand for renal replacement fluids has increased significantly worldwide. The demand for RRT among patients with COVID-19 has increased fivefold in comparison to the historical US populations (4.9% as of 2020 VS. 0.9% earlier) (Source: American Society of Nephrology, 2021). For Instance: In 2020, countries such as China and Italy reported AKI rates as high as 29% (according to International Society of Nephrology).
Request for Sample of the report browse through – https://univdatos.com/get-a-free-sample-form-php/?product_id=8988
Based on the Product Type, the market is mainly fragmented into Disposables, Machine, Dialysates, Renal Replacement fluids. The Dialysates segment dominated the market in 2020 and gathered XX % in 2020. Moreover, the segment is anticipated to maintain its dominance during the analyzed period. The largest market share of this segment is attributed to factors such growing demand for dialysates to remove undesired solutes and restoring the electrolytes and acid-base balance in the blood along with presence of well-established players with strong offerings in dialysates & replacement fluid.
Feel free to contact us for any queries – https://univdatos.com/get-a-free-sample-form-php/?product_id=8988
Additionally, the report provides detailed initiatives that are being taken in the field of Continuous Renal Replacement Therapy. The market is classified into distinct regions including North America (the U.S, Canada, Rest of North America), Europe (Germany, France, Spain, Italy, and United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, Australia, India, and the Rest of APAC), Rest of World has been conducted. North America dominated the market with US$ XX million in 2020 of prime importance, Increasing demand for CRRT techniques and enhanced innovation in machine and system manufacturing are two high-impact key drivers for the region’s growth. Furthermore, the rising prevalence of kidney illnesses in the United States is likely to drive market growth.
Global Continuous Renal Replacement Therapy Market Segmentation
Market Insight, by Product
Market Insight, by Modality
Market Insight, by Mode of Patient
Market Insight, by Region
- North America
- United States
- Rest of North America
- United Kingdom
- Rest of Europe
- Rest of Asia-Pacific
- Rest of World
Top Company Profiles
- Baxter International Inc.
- Fresenius Medical Care AG & Co. KGaA
- NIKKISO Co. Ltd.
- B. Braun Melsungen AG
- Medtronic plc
- Toray Medical Co. Ltd.
- Infomed SA
- Nipro Corporation